CA3240163A1 - Inhibiteurs de la phosphorylation anormale et de l'agregation de la proteine tau - Google Patents
Inhibiteurs de la phosphorylation anormale et de l'agregation de la proteine tau Download PDFInfo
- Publication number
- CA3240163A1 CA3240163A1 CA3240163A CA3240163A CA3240163A1 CA 3240163 A1 CA3240163 A1 CA 3240163A1 CA 3240163 A CA3240163 A CA 3240163A CA 3240163 A CA3240163 A CA 3240163A CA 3240163 A1 CA3240163 A1 CA 3240163A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- tau
- group
- formula
- nmr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306658.2 | 2021-11-29 | ||
| EP21306658 | 2021-11-29 | ||
| PCT/EP2022/083709 WO2023094699A1 (fr) | 2021-11-29 | 2022-11-29 | Inhibiteurs de la phosphorylation anormale et de l'agrégation de la protéine tau |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3240163A1 true CA3240163A1 (fr) | 2023-06-01 |
Family
ID=78851140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3240163A Pending CA3240163A1 (fr) | 2021-11-29 | 2022-11-29 | Inhibiteurs de la phosphorylation anormale et de l'agregation de la proteine tau |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250034194A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4441064A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024543187A (cg-RX-API-DMAC10.html) |
| CN (1) | CN118922429A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3240163A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023094699A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240409505A1 (en) * | 2023-06-12 | 2024-12-12 | The Procter & Gamble Company | Gluconamide sulfate surfactants |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686603A (en) * | 1995-05-04 | 1997-11-11 | Lever Brothers Company, Division Of Conopco, Inc. | Sulfated polyhydroxy compounds as anionic surfactants and a process for their manufacture |
| WO2007115372A1 (en) * | 2006-04-10 | 2007-10-18 | Monash University | A method of modulating beta-amyloid peptide production |
-
2022
- 2022-11-29 CA CA3240163A patent/CA3240163A1/fr active Pending
- 2022-11-29 JP JP2024531728A patent/JP2024543187A/ja active Pending
- 2022-11-29 WO PCT/EP2022/083709 patent/WO2023094699A1/fr not_active Ceased
- 2022-11-29 CN CN202280089714.7A patent/CN118922429A/zh active Pending
- 2022-11-29 EP EP22823041.3A patent/EP4441064A1/fr active Pending
- 2022-11-29 US US18/714,018 patent/US20250034194A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN118922429A (zh) | 2024-11-08 |
| US20250034194A1 (en) | 2025-01-30 |
| WO2023094699A1 (fr) | 2023-06-01 |
| JP2024543187A (ja) | 2024-11-19 |
| EP4441064A1 (fr) | 2024-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vuong et al. | Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies | |
| EP3116511B1 (en) | Compositions of selenoorganic compounds and methods of use thereof | |
| RU2663127C2 (ru) | Селенсодержащие композиции и их применение для лечения и предотвращения заболеваний или состояний, связанных с митохондриальной дисфункцией | |
| CN109640967B (zh) | 抑制胆碱向三甲胺(tma)的转化的方法 | |
| CN106456699A (zh) | 作为抗老化剂抑制抗凋亡的Bcl‑2蛋白的组合物和方法 | |
| Colle et al. | Succinobucol, a lipid-lowering drug, protects against 3-nitropropionic acid-induced mitochondrial dysfunction and oxidative stress in SH-SY5Y cells via upregulation of glutathione levels and glutamate cysteine ligase activity | |
| EP1231916A2 (fr) | Utilisation de derives d'indirubine pour la fabrication de medicaments | |
| Cao et al. | Derivatives of sarcodonin A isolated from Sarcodon scabrosus reversed LPS-induced M1 polarization in microglia through MAPK/NF-κB pathway | |
| Li et al. | Discovery of novel SS-31 (d-Arg-dimethylTyr-Lys-Phe-NH2) derivatives as potent agents to ameliorate inflammation and increase mitochondrial ATP synthesis | |
| US20220249411A1 (en) | Calixarene compounds and uses thereof | |
| Hwang et al. | Synthetic phytoceramides induce apoptosis with higher potency than ceramides | |
| EP4441064A1 (fr) | Inhibiteurs de la phosphorylation anormale et de l'agrégation de la protéine tau | |
| CN111344016B (zh) | 用于抑制胆碱向三甲胺(tma)的转化的方法 | |
| Li et al. | A mitochondria-targeted idebenone derivative W1a mitigates cerebral ischemia-reperfusion injury by preserving mitochondrial integrity and suppressing neuroinflammation | |
| KR102874460B1 (ko) | Aspergillus sp. SF-7402 유래 화합물을 포함하는 신경퇴행성 질환의 예방 또는 치료용 조성물 | |
| EP4291217B1 (fr) | Composition thérapeutique à base de feuilles de neurolaena inhibitrice de la dhodh pour le traitement d'infections par virus à arn | |
| KR102917789B1 (ko) | 신규한 라말린 유도체 및 이의 퇴행성 뇌질환의 예방 또는 치료 용도 | |
| RU2744453C2 (ru) | Таргетная неинвазивная трансплантация в мозг функционально активных митохондрий для лечения нейродегенеративных заболеваний | |
| US20240398889A1 (en) | Nutraceutical composition and method for the protection of human arterial endothelial cells from endothelial cell dysfunction | |
| Babylon et al. | Hesperetin Nanocrystals Improve Mitochondrial Function in a Cell Model of Early Alzheimer Disease. Antioxidants 2021, 10, 1003 | |
| EP4499225A1 (en) | Phialomustin b (1) for treatment of parkinson's disease (pd) and amyotrophic lateral sclerosis (als) | |
| FR3110395A1 (fr) | Composition comprenant un composé ascorbo-camphorate métallique pour son utilisation dans le traitement des infections causées par papillomavirus | |
| EP4408410A1 (fr) | Inhibiteurs de l'interaction entre les protéines kinases rock et pdk1 | |
| FR3121038A1 (fr) | Composition pharmaceutique destinée à inhiber l’infectiosité des virus à bicouche lipidique, à traiter les maladies associées et leurs complications. | |
| EP3600296A1 (fr) | Nouveaux composes, compositions et methodes pour le traitement de la resistance a l'insuline |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241120 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20241120 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20241120 |